Bell Global Equities Fund adds SYK to portfolio, citing strong execution and Mako robotics platform advantages amid medtech sector weakness.
Stryker Corporation (NYSE:SYK) closed at $326.85 on July 8, 2026, valuing the company at $126.11 billion. The stock posted a 7.22% gain over the past month but remains down 16.99% over the last 52 weeks.
The medical technology firm operates in MedSurg, Neurotechnology, and Orthopaedics segments. Its recent performance contrasts with broader medtech sector declines and stock-specific pressures following a March cyberattack.
Bell Global Equities Fund initiated a position in SYK, highlighting its decentralized operating model, organic revenue growth, and competitive edge through the Mako robotics platform, which drives recurring consumables revenue.